title: Aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogs inhibit neutrophil-mediated changes in vascular permeability.
authors.affiliation: Department of Anesthesia, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
authors.forename: C N
authors.initials: CN
authors.lastname: Serhan
authors.forename: T
authors.initials: T
authors.lastname: Takano
authors.forename: C B
authors.initials: CB
authors.lastname: Clish
authors.forename: K
authors.initials: K
authors.lastname: Gronert
authors.forename: N
authors.initials: N
authors.lastname: Petasis
mesh_terms: D000818:Animals; D001241:Aspirin / Q000494:pharmacology*; D002199:Capillary Permeability / Q000187:drug effects* / Q000502:physiology*; D002465:Cell Movement / Q000187:drug effects; D005233:Fatty Alcohols / Q000494:pharmacology; D006018:Glycols / Q000494:pharmacology; D006893:Hydroxyeicosatetraenoic Acids / Q000737:chemistry / Q000502:physiology*; D044045:Lipoxins; D051379:Mice; D008807:Mice, Inbred BALB C; D009504:Neutrophils / Q000187:drug effects* / Q000502:physiology*; D018102:Receptors, Leukotriene B4 / Q000037:antagonists & inhibitors / Q000502:physiology
chemical_list: D005233:Fatty Alcohols; D006018:Glycols; D006893:Hydroxyeicosatetraenoic Acids; D044045:Lipoxins; D018102:Receptors, Leukotriene B4; C040527:lipoxin A4; C062137:U 75302; C042651:lipoxin B4; D001241:Aspirin